CoChat

Multiple functional domains of the oncoproteins Spi-1/PU.1 and TLS are involved in their opposite splicing effects in erythroleukemic cells

Delva, Laurent, Gallais, Isabelle, Guillouf, Christel, Denis, Nicole, Orvain, Christophe, Moreau-Gachelin, Francoise · 2004 · Oncogene

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

The hematopoietic transcription factor Spi-1/PU.1 is an oncoprotein participating to the malignant transformation of proerythroblasts in the Friend erythroleukemia or in the erythroleukemic process developed in spi-1 transgenic mice. Overexpression of Spi-1 in proerythroblasts blocks their differentiation. We have shown that Spi-1 promotes the use of the proximal 5'-splice site during the E1A pre-mRNA splicing and interferes with the effect of TLS (Translocated in LipoSarcoma) in this splicing assay. TLS was identified from chromosomal translocations in human liposarcoma and acute myeloid leukemia. Here, we determine the function of Spi-1 domains in splicing and in the interference with TLS. In transient transfection assays in erythroid cells, we show that the DNA binding domain cooperates with the transactivation domain or the PEST region of Spi-1 to modify the function of TLS in splicing. Interestingly, the 27 C-terminal amino acids, which determine the DNA binding activity of Spi-1, are necessary for the splicing function of Spi-1 as well as for its ability to interfere with TLS. Finally, we demonstrate that in leukemic proerythroblasts overexpressing Spi-1, TLS has lost its splicing effect. Thus, we hypothesize that oncogenic pathways in proerythroblasts may involve the ability of Spi-1 to alter splicing.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.onc.1207578

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists are queued

They are fetched later and appear here then.

References 49 · Cited by 26

Research works printed but not linked: 1

  1. Yang L, Embree LJ and Hickstein DD . (2000). Mol. Cell. Biol., 20, 3345–3354. · doi:10.1128/mcb.20.10.3345-3354.2000 · Paper page

Metadata

Authors
Delva, L., Gallais, I., Guillouf, C., Denis, N., Orvain, C., & Moreau-Gachelin, F.
Affiliations
Inserm (FR)
Venue
Oncogene
Published
2004-04-05
Volume
23
Issue
25
Pages
4389-4399
ISSN
  • 0950-9232 (ISSN-L)
  • 1476-5594
OpenAlex
W2058890884
Cited by
26
References
49
Citations by year
2025: 1 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 1 · 2017: 1 · 2016: 1 · 2015: 2 · 2014: 1 · 2012: 1
FWCI
0.59
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Oncogene (publishedVersion)
  • PubMed (publishedVersion)
Funders
Ligue Contre le Cancer
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
Keywords
TLS, alternative splicing, erythroleukemia, proerythroblasts, DNA-binding domain, transactivation domain, leukemic transformation
MeSH terms
Proto-Oncogene Protein Spi-1, Animals, Binding Sites, Cell Transformation, Neoplastic, DNA, Leukemia, Erythroblastic, Acute, Protein Binding, Proto-Oncogene Proteins, RNA Precursors, RNA Splicing, RNA, Neoplasm, Structure-Activity Relationship, Transfection, Neoplastic Stem Cells, Transcriptional Activation, Trans-Activators, Erythroid Precursor Cells, Protein Structure, Tertiary, Adenovirus E1A Proteins, Genes, Reporter, RNA Splice Sites, RNA-Binding Protein FUS, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Multiple functional domains of the oncoproteins Spi-1/PU.1 and TLS are involved in their opposite splicing effects in erythroleukemic cells. https://app.cochat.ai/papers/10.1038/sj.onc.1207578
The paper
Delva, L., Gallais, I., Guillouf, C., Denis, N., Orvain, C., & Moreau-Gachelin, F. (2004). Multiple functional domains of the oncoproteins Spi-1/PU.1 and TLS are involved in their opposite splicing effects in erythroleukemic cells. Oncogene. https://doi.org/10.1038/sj.onc.1207578

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.